Urologic Oncology: Seminars and Original Investigations
Review articleDevelopment of markers of prostate cancer metastasis: Review and perspective☆,☆☆
Section snippets
Markers for molecular diagnosis—the emerging role of metastasis-suppressor genes
Metastasis is defined as the formation of progressively growing secondary tumor foci at a site discontinuous from the primary lesion [11]. Metastases can form following invasion into adjacent tissues and dissemination of cells by the lymphatic system and/or blood vasculature. During transport, cells travel individually or as emboli composed of tumor cells or tumor cells and host cells. At the secondary site, cells or emboli arrest either because of their physical size or by binding to specific
The quest for biological markers of metastasis
During the past 35 years, we have witnessed a revolution in our perceptions regarding the etiology of cancer.2 We now have an increased understanding of the genetic basis of neoplasia, the nonrandom nature of metastasis, and the specific molecular changes associated
Future directions
New technologies will continue to increase our ability to detect sensitively both localized cancer and disseminated cancer cells. Our challenge is to identify genetic markers that can be used to improve the value of these emerging technologies. The immediate goal is to improve the ability of the pathologist to unambiguously distinguish malignant from indolent lesions [4]. The practical question is how to identify and develop these markers. When we started this research, the identification of
Acknowledgements
We would like to express our thanks to Dr. Thomas Pretlow for his insightful comments regarding the early efforts to detect cancer cells in the circulation. We appreciate greatly the critical comments of our colleagues Drs. Gail Prins, Robert Radinsky, and Kerry Burnstein during the preparation of this manuscript.
References (62)
The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer
J Urol
(1993)Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control
Urol Clin North Am
(1997)- et al.
Prostate specific antigenA decade of discovery—what we have learned and where we are going
J Urol
(1999) - et al.
Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer
J Urol
(1997) KAI1, a putative marker for metastatic potential in human breast cancer
Cancer Lett
(1997)The role of the matrix metalloproteinase stromelysin in the progression of squamous cell carcinomas
Am J Med Sci
(1991)Frequent loss of KAI1 expression in squamous and lymphoid neoplasms. An immunohistochemical study of archival tissues
Am J Pathol
(1999)Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay
Urology
(1994)Quantitative polymerase chain reaction does not improve preoperative prostate cancer stagingA clinicopathological molecular analysis of 121 patients
J Urol
(1996)The significance of the circulating cancer cell
Cancer Treat Rev
(1975)
An expressed-sequence-tag database of the human prostateSequence analysis of 1168 cDNA clones
Genomics
Cancer statistics, 1999
CA Cancer J Clin
The natural history of localized prostate cancer
Diagnosis and staging of prostate cancer
Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer
Am J Pathol
Morphologic analysis of surgical margins with positive findings in prostatectomy for adenocarcinoma of the prostate
Cancer
The pathogenesis of cancer metastasis
Nature
What defines a useful marker of metastasis in human cancer?
J Natl Cancer Inst
Molecular basis of tumour metastasis
Cancer Surv
Evidence for a novel gene associated with low tumor metastatic potential
J Natl Cancer Inst
Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss
Cancer Res
ReviewBiologic heterogeneity of cancer metastases
Breast Cancer Res Treat
Angiogenesis and angiogenesis inhibitionAn overview
Exs
Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
Science
Critical factors in the biology of human cancer metastasisTwenty-eighth G.H.A. Clowes memorial award lecture
Cancer Res
A fluorescent orthotopic bone metastasis model of human prostate cancer
Cancer Res
Recent observations on concepts of metastasis
Arch Pathol
Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique
Am J Pathol
Detection and clinical importance of micrometastatic disease
J Natl Cancer Inst
Prostate cancer metastasis-suppressor genesA current perspective
In Vivo
Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers
Prostate
Cited by (22)
Prostate cancer: A presentation of clinicopathologic prognosticators among Filipino and American men at radical prostatectomy
2021, Asian Journal of AndrologyCorrelation of E-cadherin expression with clinicopathological parameters and its outcomes among prostate cancer patients in Hospital Kuala Lumpur
2020, Malaysian Journal of Medicine and Health SciencesVerticillin A inhibits colon cancer cell migration and invasion by targeting c-Met
2020, Journal of Zhejiang University: Science BDefining the Hallmarks of Metastasis
2019, Cancer Research
- ☆
This work was supported by American Cancer Society Institutional Grant, IGR41-35-3, NIH P20 CA 66132, University of Chicago Surgery Research Committee Grant; Cancer Research Foundation Young Investigator Award and NIH First Award R29 CA69487 02 (C.W.R.-S.); American Foundation for Urologic Disease (B.A.Y., C.W.R.-S.); and University of Chicago RESCUE Fund (B.A.Y., Z.D.)